GPX3 and colorectal carcinoma: Subsequent studies will focus on the specific regulatory mechanisms of GEM on CALB2 and GPX3 as well as a large sample multicenter prospective study to explore the effects of GEM combination with targeted therapies on CRC, leading to the development of novel therapeutic tools.